Cancer Vaccines Market Size 2022- Global Growth Analysis, Share, Industry Demand Facts, Industry Development Figures, Updated Trends, Driving Factor to Hit High Growth By 2028 - PowerPoint PPT Presentation

About This Presentation
Title:

Cancer Vaccines Market Size 2022- Global Growth Analysis, Share, Industry Demand Facts, Industry Development Figures, Updated Trends, Driving Factor to Hit High Growth By 2028

Description:

The cancer vaccines assist in the treatment of the existing cancer or prevent the development of cancer; the former are known as therapeutic cancer vaccines. Several vaccines are "autologous," as they are prepared from the samples obtained from cancer patients, and such vaccines are unique to that patient. Cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. – PowerPoint PPT presentation

Number of Views:2
Slides: 9
Provided by: nikhilghodse94@gmail
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Cancer Vaccines Market Size 2022- Global Growth Analysis, Share, Industry Demand Facts, Industry Development Figures, Updated Trends, Driving Factor to Hit High Growth By 2028


1
Cancer Vaccines Market Global Analysis and
Forecast to 2028
  • Published Date Sep 2020

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com
  • Cancer Vaccines Market Forecast to 2027 -
    COVID-19 Impact and Global Analysis by Technology
    (Dendritic Cells Cancer Vaccines, Recombinant
    Cancer Vaccines, Antigen Cancer Vaccines, Whole
    Cell Cancer Vaccines and Viral Vector Cancer
    Vaccines), Type (Preventive Cancer Vaccines and
    Therapeutic Cancer Vaccines), Indication
    (Cervical Cancer, Prostate Cancer and Other
    Indications), End User (Pediatrics and Adults)
    and Geography

3
Cancer Vaccines Market Overview
Email sales_at_theinsightpartners.com
  • The Cancer Vaccines Market is expected to reach
    US 15,845.59 million by 2027 from US 4,568.82
    million in 2019 the market is estimated to grow
    at a CAGR of 17.2 from 2020 to 2027.
  • The cancer vaccines assist in the treatment of
    the existing cancer or prevent the development of
    cancer the former are known as therapeutic
    cancer vaccines. Several vaccines are
    "autologous," as they are prepared from the
    samples obtained from cancer patients, and such
    vaccines are unique to that patient. Cancer
    vaccines can be of two type, therapeutic vaccine
    and preventive vaccines. Cervarix, Gardasil,
    Gardasil-9, and Hepatitis B (HBV) vaccine
    (HEPLISAV-B) are preventive cancer vaccines,
    whereas, Sipuleucel-T (Provenge) are therapeutic
    cancer vaccines.

4
Key Segment Market
Email sales_at_theinsightpartners.com
  • Segment By Type-
  • By Type (Preventive Cancer Vaccines and
    Therapeutic Cancer Vaccines)
  • Indication (Cervical Cancer, Prostate Cancer and
    Other Indications)
  • End-User (Pediatrics and Adults)

Download Sample Here
5
Cancer Vaccines Market Value
Email sales_at_theinsightpartners.com
  • CAGR of 17.2
  • (2020 - 2027)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com
  • CSL Limited
  • ADURO BIOTECH INC.
  • Astellas Pharma Inc.
  • Merck Co., Inc.
  • Sanofi
  • Bristol-Myers Squibb Company
  • Glaxosmithkline Plc.
  • Dendreon
  • ASTRAZENECA PLC.
  • OSE Immunotherapeutics

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com
  • North America (the US, Canada, and Mexico)
  • Europe (the UK, Germany, France, Italy, Spain,
    and the Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia,
    South Korea, and the Rest of Asia Pacific)
  • Middle East Africa (the UAE, Saudi Arabia,
    South Africa, and the Rest of Middle East
    Africa)
  • South Central America (Brazil, Argentina, and
    the Rest of South Central America).

8
THANKYOU!
  • Phone  1-646-491-9876
  • E-Mail sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com